Quantitatively identifying the emission sources of pharmaceutically active compounds (PhACs) in the surface water: Method development, verification and application in Huangpu River, China

Author(s):  
Xiping Kan ◽  
Shengya Feng ◽  
Xuebing Mei ◽  
Qian Sui ◽  
Wentao Zhao ◽  
...  
2007 ◽  
Vol 42 (4) ◽  
pp. 231-239 ◽  
Author(s):  
Viviane Yargeau ◽  
Antonina Lopata ◽  
Chris Metcalfe

Abstract Pharmaceutically active compounds have been detected in North America and Europe in groundwater, surface water, wastewater, and drinking water. In the province of Quebec in Canada, there has been little data to assess the occurrence of pharmaceutical residues in the aquatic environment. In August of 2005, samples of surface water were collected at 10 sites along the Yamaska River basin in Quebec, which passes through important agricultural areas and receives wastewater from several urban centers with populations ranging up to 44,000 residents. Several acidic drugs (naproxen, ibuprofen, gemfibrozil), neutral drugs (caffeine, carbamazepine, cotinine), and the sulfonamide antibiotic sulfamethoxazole were detected in the majority of the surface water samples. The antidepressant fluoxetine (neutral/basic drug) was not detected in any samples, while acetaminophen (acidic drug) was detected at only two sites, and sulfapyridine (sulfonamide antibiotic) was detected at only one site. Sulfamethoxazole and carbamazepine were present at the highest maximum concentrations of 578 ng/L and 106 ng/L, respectively. The concentrations of most of the target pharmaceutically active compounds observed in surface water samples within the watershed were generally consistent with the number of people in urban centers near the sampling sites when compared with other studies in urban watersheds. However, carbamazepine, naproxen, and sulfamethoxazole were present at surprisingly high concentrations for some of the low density areas. Overall, these results demonstrate that pharmaceuticals are distributed in surface waters within a watershed in Quebec at concentrations similar to levels observed in previous studies done in other parts of North America.


2018 ◽  
Vol 69 (1) ◽  
pp. 34-37 ◽  
Author(s):  
Monica Ihos ◽  
Corneliu Bogatu ◽  
Carmen Lazau ◽  
Florica Manea ◽  
Rodica Pode

The aim of this study was the investigation of photocatalytic degradation of pharmaceutically active compounds using doped TiO2 functionalized zeolite photocatalyst. Diclofenac (DCF), a non-steroidal anti-inflammatory drug, that represents a biorefractory micropollutant, was chosen as model of pharmaceutically active compound. The photocatalyst was Z-TiO2-Ag. The concentration of DCF in the working solutions was 10 mg/L,50 mg/L,100 mg/L and 200 mg/L and of photocatalyst 1 g/L in any experiments. The process was monitored by recording the UV spectra of the treated solutions and total organic carbon (TOC) determination. The UV spectra analysis and TOC removal proved that along the advanced degradation of DCF also a mineralization process occurred. The carried out research provided useful information envisaging the treatment of pharmaceutical effluents by photocatalysis.


Sign in / Sign up

Export Citation Format

Share Document